Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates peripheral blood lymphocytes engineered with a murine T-cell receptor targeting the G12V mutation in…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer [Phase 1]
A Phase 1 clinical trial evaluating a Personalized Peptide Vaccine for advanced colorectal cancer and pancreatic cancer is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for Metarrestin (ML-246) in subjects with metastatic solid tumors; the study is currently recruiting across mu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) [Phase 1]
A Phase 1 trial evaluating gemcitabine with or without pitavastatin as the primary therapy for unresectable pancreatic adenocarcinoma; curre…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation [Phase 2]
ClinicalTrials.gov update describes a Phase II randomized study (APOLLO) comparing olaparib versus placebo after curative-intent therapy in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating the anti-CEACAM5 antibody-drug conjugate M9140 in adults with advanced solid tum…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy [NA]
This clinical trial compares a superior mesenteric artery-first approach versus the standard approach during pancreaticoduodenectomy for pan…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial evaluating the combination of gemcitabine, erlotinib, and nab-paclitaxel in basal-like pancreatic …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pancreatic Cancer Screening for At-risk Individuals
A clinical trial update indicating recruitment for pancreatic cancer screening in at-risk individuals is currently ongoing.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: EUS-CPN With and Without Bupivacaine [NA]
A clinical trial evaluating endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) with and without bupivacaine for pancreatic canc…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
The Mayo Clinic-sponsored Pancreatic Cancer Detection Consortium (PCDC) reports a recruiting status for its prospective cohorts studying pan…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
The update details a study to collect solid tumor tissue from people undergoing biopsy or surgery for colorectal, gastric, cholangiocarcinom…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Pancreatic Cancer Early Detection Consortium
The Pancreatic Cancer Early Detection Consortium trial is currently recruiting to study early detection of pancreatic cancer and related pan…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients [NA]
Clinical trial update for e-Health Psychosocial Stress and Symptom Management (ePSMI) in pancreatic cancer patients; the study is not yet re…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Supportive Oncology Care At Home RCT [NA]
Clinical trial update on an at-home supportive oncology care program; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study [Phase 2]
This is a Phase 2 prospective exploratory trial evaluating a multi-drug regimen (liposomal irinotecan, 5-fluorouracil with leucovorin, oxali…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens [NA]
ARTIDIS AG is evaluating nanomechanical signature profiling on pancreatic cancer specimens in a clinical trial. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma
A clinical trial update describes a cohort of patients with pancreatic cancer treated in a study on convertases; the trial is currently recr…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update on intratumoral MMR vaccine injection for borderline resectable/unresectable pancreatic cancer (Phase 1/2); the study …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.
The document describes a planned ambispective validation study of the Odesa Criteria 2026 for diagnosing autoimmune pancreatitis and related…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating orally administered MOMA-313 in adults with advanced or metastatic solid tumors; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4337713 in Participants With FAP-Positive Solid Tumors [Phase 1]
A Phase 1 clinical trial update for LY4337713 in participants with FAP-positive solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of PHN-012 in Patients With Advanced Solid Tumors [Phase 1]
PHN-012 is being studied in a Phase 1 trial for patients with advanced solid tumors and is currently recruiting. The listed conditions inclu…